journal
https://read.qxmd.com/read/38334173/use-of-therapeutic-plasma-exchange-to-remove-lipoprotein-x-in-a-patient-with-vanishing-bile-duct-syndrome-presenting-with-cholestasis-pseudohyponatremia-and-hypercholesterolemia-a-case-report-and-review-of-literature
#21
JOURNAL ARTICLE
Yujung Jung, Heather A Nelson, David Ming-Hung Lin
INTRODUCTION: Lipoprotein X (Lp-X) is an abnormal lipoprotein found in multiple disease conditions, including liver dysfunction and cholestasis. High Lp-X concentrations can interfere with some laboratory testing that may result in spurious results. The detection of Lp-X can be challenging, and there is currently a lack of consensus regarding the management of Lp-X other than treating the underlying disease. CASE PRESENTATION: A 42-year-old female with Hodgkin's lymphoma treated with dexamethasone, high dose cytarabine and cisplatin and vanishing bile duct syndrome confirmed by liver biopsy presented with cholestasis, pseudohyponatremia (sodium, 113 mmol/L; reference range 136-146 mmL/L; serum osmolality, 303 mOsm/kg), and hypercholesterolemia (> 2800 mg/dL, reference range < 200 mg/dL)...
February 2024: Journal of Clinical Apheresis
https://read.qxmd.com/read/38334167/evaluation-of-a-scoring-system-for-vein-suitability-in-platelet-apheresis-donors
#22
JOURNAL ARTICLE
Shahida Noushad, Abhishekh Basavarajegowda, Esha Toora, Dibyajyoti Sahoo, K M Hari Priya
INTRODUCTION: Donor vein assessment for the selection of good quality veins is crucial for a successful apheresis procedure. This study intends to find out the effectiveness of a vein assessment scoring tool (VST) used and found to be effective in selecting whole blood donors to reduce the difficulty in identifying good quality veins for the plateletpheresis procedure. MATERIALS AND METHODS: This was a prospective observational study on platelet apheresis donors with the application of a VST consisting of three vein descriptor parameters (vein visibility, vein palpability, and vein size) with 5 Likert-type responses constituting a score of 0-12 for each arm...
February 2024: Journal of Clinical Apheresis
https://read.qxmd.com/read/37990778/a-retrospective-study-to-investigate-the-efficacy-and-safety-of-granulocyte-and-monocyte-adsorptive-apheresis-in-patients-with-primary-sclerosing-cholangitis-with-ulcerative-colitis
#23
JOURNAL ARTICLE
Ayumi Ito, Shun Murasugi, Maria Yonezawa, Teppei Omori, Shinichi Nakamura, Katsutoshi Tokushige
BACKGROUND AND AIMS: Primary sclerosing cholangitis has a poor prognosis and can be accompanied by ulcerative colitis. Infection control is essential, so immunosuppressive drugs should ideally be preferably. Granulocyte and monocyte adsorptive apheresis does not suppress the immune system and is used to treat ulcerative colitis. Therefore, this study investigated the efficacy and safety of granulocyte and monocyte adsorptive apheresis in patients with primary sclerosing cholangitis and ulcerative colitis...
February 2024: Journal of Clinical Apheresis
https://read.qxmd.com/read/38186371/safety-and-efficacy-of-peripheral-blood-stem-cells-collection-in-healthy-children-and-pediatric-patients-with-thalassemia-major-weighing-20%C3%A2-kg-or-less
#24
JOURNAL ARTICLE
Libai Chen, Jianyun Wen, Xiaoxiao Xu, Jing Du, Yongsheng Ruan, Xiaoqin Feng, Juan Li, Yuelin He, Xuedong Wu
BACKGROUND: Peripheral blood stem cell (PBSC) collection in children poses challenges due to their small size, low body weight (BW), and unique pediatric physiology, especially among children weighing 20 kg (kg) or less. METHODS: PBSC collection data of both healthy children and patients with thalassemia major (TM) weighing 20 kg or less between January 2013 and December 2020 were reviewed. Moreover, PBSCs characteristics along with various aspects of efficiency and safety between healthy donors and patients with TM were compared...
January 8, 2024: Journal of Clinical Apheresis
https://read.qxmd.com/read/38098278/a-single-center-retrospective-study-comparison-between-centrifugal-separation-plasma-exchange-with-acd-a-and-membrane-separation-plasma-exchange-with-heparin-on-acute-liver-failure-and-acute-on-chronic-liver-failure
#25
JOURNAL ARTICLE
Xin-Fang Zhu, Jia-Qiang Li, Tian-Tian Liu, Yuan Wang, Yao Zhong, Qing-Mei Gao, Qi Zhang, Kang-Kang Yu, Chong Huang, Ning Li, Qing Lu, Wen-Hong Zhang, Ji-Ming Zhang, Rong Xia, Jian-Ming Zheng
The purpose of this retrospective study is to compare the efficacy and safety of the centrifugal separation therapeutic plasma exchange (TPE) using citrate anticoagulant (cTPEc) with membrane separation TPE using heparin anticoagulant (mTPEh) in liver failure patients. The patients treated by cTPEc were defined as cTPEc group and those treated by mTPEh were defined as mTPEh group, respectively. Clinical characteristics were compared between the two groups. Survival analyses of two groups and subgroups classified by the model for end-stage liver disease (MELD) score were performed by Kaplan-Meier method and were compared by the log-rank test...
December 14, 2023: Journal of Clinical Apheresis
https://read.qxmd.com/read/38054256/microrna-and-granulocyte-monocyte-adsorption-apheresis-combotherapy-after-inadequate-response-to-anti-tnf-agents-in-ulcerative-colitis
#26
JOURNAL ARTICLE
Esteban Sáez-González, Inés Moret-Tatay, Guillermo Bastida, Mariam Aguas, Marisa Iborra, Pilar Nos, Belén Beltrán
BACKGROUND: Ulcerative colitis (UC) is an inflammatory bowel disease characterized by chronic inflammation of the gastrointestinal tract, affecting millions of individuals throughout the world, and producing an impaired health-related quality of life. Granulocyte and monocyte apheresis (GMA) is a therapeutic option for UC management to induce remission by selective removal of activated leukocytes from bloodstream. Despite the knowledge of the important role of epigenetics in UC pathogenesis, and in the response to different treatments, nothing is known about the role of microRNAs in GMA therapy in UC patients...
December 6, 2023: Journal of Clinical Apheresis
https://read.qxmd.com/read/38037757/validation-of-nivestym-compared-to-neupogen-an-nmdp-analysis
#27
JOURNAL ARTICLE
Joseph Maakaron, Katie Picotte, Kevin Tram, Ruth Bakken, Jason Oakes, Meghann Cody, John Miller, Steven M Devine, Heather E Stefanski
No abstract text is available yet for this article.
December 1, 2023: Journal of Clinical Apheresis
https://read.qxmd.com/read/37519096/therapeutic-leukocytapheresis-for-leukostasis-in-chronic-lymphocytic-leukemia-a-case-report-and-literature-review
#28
REVIEW
Thomas Auen, Pranav Renavikar, Esther Habib, Scott A Koepsell
Chronic lymphocytic leukemia (CLL) is a clonal mature B-cell neoplasm with a typically indolent clinical course. Though most clinicians follow these neoplasms through observation alone, an aggressive transformation to prolymphocytic leukemia, diffuse large-B-cell lymphoma (Richter transformation) or classical Hodgkin lymphoma requires immediate attention. We present a case of extreme leukocytosis (>1 million/μL) in a previously diagnosed CLL patient. Due to symptomatic leukostasis, she was started on cytoreductive therapies including leukocytapheresis...
December 2023: Journal of Clinical Apheresis
https://read.qxmd.com/read/37519071/botulism-mimicking-guillain-barre-syndrome-the-question-of-plasma-exchange-in-an-unusual-case-of-acute-paralysis
#29
Juan J Silva Campos, Elizabeth Abels, Henry M Rinder, Christopher A Tormey, Jeremy W Jacobs
Guillain-Barré syndrome (GBS) is an immune-mediated polyradiculoneuropathy and the most common cause of acute flaccid paralysis worldwide. GBS classically presents with acute, progressive, ascending weakness, reduced to absent reflexes, and albuminocytological dissociation on cerebrospinal fluid (CSF) analysis. Botulism is a neurotoxin-mediated acute descending flaccid paralysis with cranial nerve palsies and dysautonomia. Botulism in adults is caused by ingestion/inhalation of botulinum toxin or wound infection with Clostridium botulinum...
December 2023: Journal of Clinical Apheresis
https://read.qxmd.com/read/37990775/therapeutic-plasma-exchange-in-refractory-susac-s-syndrome-a-brief-report
#30
JOURNAL ARTICLE
Ryan D Salazar, Krystol R Weidner, Caroline R Alquist
Susac's syndrome (SuS) is an autoimmune endotheliopathy that typically presents with the clinical triad of encephalopathy, hearing loss, and branch retinal artery occlusion. It has a wide range of possible presentations, and its pathogenesis remains uncertain. Fulminant and refractory cases are difficult to treat, and no standard treatment protocol has been established. However, therapeutic plasma exchange (TPE) has been described as an adjunctive therapy in several SuS cases. Herein we present a case of a 63-year-old male with debilitating encephalopathy and recent hearing and vision loss, who responded favorably to TPE...
November 21, 2023: Journal of Clinical Apheresis
https://read.qxmd.com/read/37986652/fractionated-plasma-separation-and-adsorption-integrated-with-continuous-veno-venous-hemofiltration-in-patients-with-acute-liver-failure-a-single-center-experience-from-china
#31
JOURNAL ARTICLE
Jianhua Dong, Li Huang, Chuan Li, Bian Wu, Xi Yang, Yongchun Ge
OBJECTIVE: To evaluate the clinical efficacy and safety of fractionated plasma separation and adsorption integrated with continuous veno-venous hemofiltration (FPSA-CVVH) treatment in patients with acute liver failure (ALF). METHODS: In this retrospective study, we enrolled patients with ALF (serum total bilirubin >10 mg/dL or Model for End-Stage Liver Disease [MELD] Score >18) hospitalized between August 2017 and August 2022. All patients had at least two sessions of FPSA-CVVH...
November 20, 2023: Journal of Clinical Apheresis
https://read.qxmd.com/read/37941512/vascular-access-for-autologous-peripheral-blood-stem-cells-collection-by-large-volume-leukapheresis-single-center-experience
#32
JOURNAL ARTICLE
Ines Bojanić, Greta Novosel, Marijana Lukač Baričević, Petar Škrnjug, Elena Horvat, Sanja Mazić, Josip Batinić, Sandra Bašić Kinda, Branka Golubić Ćepulić
INTRODUCTION: Peripheral blood stem cell (PBSC) harvesting requires reliable and safe vascular access. In our institution, a change of practice was implemented and the central venous catheter (CVC) placement for all autologous PBSC collections was abandoned in favor of a careful evaluation of peripheral venous access (PVA) for each individual patient. The aim of this prospective study was to evaluate the rate of patients with adequate peripheral veins for autologous PBSC collection and compare patient characteristics, collection efficacy, and complication rate between patients with PVA and CVC...
November 8, 2023: Journal of Clinical Apheresis
https://read.qxmd.com/read/37937412/crude-collection-efficiency-of-cd34-hematopoietic-stem-cell-apheresis
#33
JOURNAL ARTICLE
Yandy Marx Castillo-Aleman
Understanding the apheresis principles for harvesting hematopoietic stem cells (HSCs) is critical for performing efficient procedures. However, despite significant advances in estimating the collection efficiency (CE) of aphereses, many confounding factors still need to be addressed in the classical calculations. The CE values are unrestricted, and many procedures exhibit CEs of a given cell population greater than 100%. This report introduces a simple equation that estimates the "crude" CE, which ranges from 0% to 100% and intrinsically considers the contribution of donor-related variables such as the pre-procedure mobilization and intra-apheresis recruitment of CD34+ cells (as a convenient marker for HSCs), as well as the performance of the apheresis system itself...
November 8, 2023: Journal of Clinical Apheresis
https://read.qxmd.com/read/37855194/comorbidity-in-lipoprotein-apheresis-their-role-in-the-era-of-new-lipid-lowering-therapies
#34
JOURNAL ARTICLE
Francesco Sbrana, Mascia Pianelli, Roberta Luciani, Federico Bigazzi, Carmen Corciulo, Andrea Ripoli, Tiziana Sampietro, Beatrice Dal Pino
BACKGROUND: Despite advance in pharmacotherapy of lipid disorders, lipoprotein apheresis (LA) plays a leading role in the management of severe hypercholesterolemia and in atherosclerosis prevention. METHODS: Aim of this study was to retrospectively evaluate Charlson Comorbidity Index (CCI), presence of major comorbidity, and/or concomitant polypharmacy (definite as 5+ drugs daily) in patients with inherited dyslipidemias on chronic LA. RESULTS: Since 1994, we performed more than 500 LA treatment/year and followed a total of 83 patients (age 56 [47-65] years, male 75%)...
October 19, 2023: Journal of Clinical Apheresis
https://read.qxmd.com/read/37850483/therapeutic-plasma-exchange-for-mechanical-red-cell-hemolysis-a-case-series
#35
Chloe E Douglas, Taylor R House, Larissa Yalon, Shina Menon
We present three cases of severely elevated plasma free hemoglobin (PFH) in pediatric patients on mechanical circulatory support devices at a tertiary pediatric care center. Due to severe levels of PFH in the setting of critical illness with the inability to pursue immediate mechanical device exchange, membrane filtration therapeutic plasma exchange (TPE) was performed, which resulted in a lowering of PFH levels. However, long-term outcomes were heterogeneous across the cases. This case series reviews patient presentation, organ function before and after TPE, and the overall role of TPE as an effective treatment option to decrease severely elevated PFH levels...
October 18, 2023: Journal of Clinical Apheresis
https://read.qxmd.com/read/37800533/hyperchloremic-metabolic-acidosis-after-plasma-exchange-in-a-patient-with-renal-transplant-rejection-a-case-report
#36
S S A Simon, M S van Sandwijk, R H G Olde Engberink
Therapeutic plasma exchange (TPE) is an effective treatment for several renal disorders, including renal transplant rejection. However, repeated plasma exchanges can result in various metabolic disturbances and complications. We present a 61-year old male with a medical history of type 2 diabetes, hypertension, successfully treated multiple myeloma, and a post-mortem kidney transplantation 7 months prior to presentation. The patient was hospitalized with an antibody-mediated transplant rejection for which treatment with methylprednisolone, TPE with a 40 g/L albumin solution as a replacement fluid, and intravenous immunoglobulins was initiated...
October 6, 2023: Journal of Clinical Apheresis
https://read.qxmd.com/read/37787399/adsorptive-cytapheresis-in-ulcerative-colitis-a-non-pharmacological-therapeutic-approach-revisited
#37
REVIEW
Filippo Vernia, Angelo Viscido, Giovanni Latella
Adsorptive cytapheresis proves effective in a proportion of patients affected by ulcerative colitis. Relatively high cost and the need for apheresis facilities, prevented the widespread use of this therapeutic approach. More so following the introduction of anti-TNFα biosimilars which proved both effective and inexpensive. Anti-TNFα agents, however, are burdened by high rate of primary and secondary non-response and prompt switching to new, high-cost biologics, and small molecules. The present review analyzes advantages and disadvantages of adsorptive cytapheresis in the present clinical scenario and suggests its repositioning in the therapeutic workup of selected subgroups of ulcerative colitis patients...
October 3, 2023: Journal of Clinical Apheresis
https://read.qxmd.com/read/37786990/effectiveness-of-leukapheresis-on-early-survival-in-acute-myeloid-leukemia-an-observational-propensity-score-matching-cohort-study
#38
JOURNAL ARTICLE
Howon Lee, Jay Ho Han, Jae Kwon Kim, Jaeeun Yoo, Hyung Suk Cho, Jae-Ho Yoon, Byung Sik Cho, Hee-Je Kim, Jihyang Lim, Dong Wook Jekarl, Yonggoo Kim
BACKGROUND: The association between leukapheresis (LK) as a treatment option for hyperleukocytosis (HL) in patients with acute myeloid leukemia (AML) remains controversial. METHODS: Data were extracted from the electronic medical record for 2801 patients with AML between April 2009 and December 2019. LK was performed when the leukocyte count was ≥100 × 109 /L at the time initial bone marrow examination. RESULTS: A comparison between the patients with HL in the non-LK (n = 1579) and LK (n = 208) groups revealed survival probabilities (%) of 93...
October 3, 2023: Journal of Clinical Apheresis
https://read.qxmd.com/read/37746743/updates-on-the-mobilization-pipeline-for-hematopoietic-stem-cell-collection
#39
REVIEW
Minh-Ha Tran, Muharrem Yunce
Hematopoetic Stem Cell Transplantation is a life saving procedure which requires mobilization of stem cells for apheresis procedure. In this review we aimed to examine mobilizing agents that are in use and under investigation. Apheresis practitioners who oversee stem cell collections should be familiar with the recent advances in mobilization agents to utilize most up-to-date information for better patient outcomes.
September 25, 2023: Journal of Clinical Apheresis
https://read.qxmd.com/read/37706521/therapeutic-plasma-exchange-decreases-plasma-anti-sars-cov-2-spike-igg-without-increasing-the-proximate-incidence-of-covid-19
#40
JOURNAL ARTICLE
Jensyn Cone Sullivan, Steven E Conklin, Stephanie Conrad, Coby Horowitz, Mark Diethelm, Raymond Comenzo
BACKGROUND: Therapeutic plasma exchange (TPE) removes both pathologic and protective immunoglobulins (Ig). SARS-CoV-2 immunity is partially mediated by anti-SARS-CoV-2 spike antibodies (SAb), which impair viral host-cell invasion. Nonetheless, the systematic effect of TPE on SAb concentration and SARS-CoV-2 immunity is unknown. METHODS: Paired plasma waste specimens from the first (first-TPE) and last (last-TPE) TPE treatment were collected from 9 patients between July 21, 2021 and March 1, 2022...
September 14, 2023: Journal of Clinical Apheresis
journal
journal
28458
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.